Ikarian Capital

Ikarian Capital is a Dallas-based venture capital firm investing in U.S. biotechnology, life sciences and pharmaceutical companies. The firm focuses on biotech and drug discovery businesses advancing therapeutic development, including innovations across early- to late-stage clinical trials, and is a fit for science-driven founders seeking early-stage VC capital in therapeutics and related life sciences markets.